1,10-菲咯啉及其衍生物铜配合物的抗癌活性研究进展

作为一种微量生命元素,铜在生物进程中扮演着重要角色,很多铜配合物呈现抑制癌细胞增殖的活性。本文论述了以1,10-菲咯啉及其衍生物为配体的铜配合物的抗癌活性研究进展,分析了其对DNA裂解的可能机理。对比顺铂类抗癌药物,展望了铜配合物作为抗癌药物的应用前景。     

Synthesis and crystal structure of chain [Cu_2I_2(PPh_3)_2(C_4H_5N_3)]∝

The chain [ Cu2I2(PPh3)2(C4H5N3)] has been synthesized and characterized by X-ray crystallography.It crystallizes in the triclinic system,space group P 1,with a=0.9985(2)nm,b=1.0998(2)nm,c=1.5174(2)nm,a=87.89(1),P=76.73(l),7=77.77(1),V=1.5849(5)nm3,Z=2,Bc=2.095g/cm3 [Gu2I2(PPh3)2(Crh5N3)] has a dimmer unit [Cu2I2(PPh3)2(C4H5N3)].The two N atoms of the phenyl ring of 2-aminopyrimidine bridge two [CuI(PPh3)]2 units,by which a one-dimensional chain is constructed.The van der Waals force makes the molecules arrange in the three-dimensional space.     

(NH3CH2CHNH2CH3)2[WVIO2(OC6H4O)2]的合成、晶体结构及其与ATP相互作用的NMR性质研究

在室温下, 选用具有手性特征的1,2-丙二胺(1,2-propanediamine)为对阳离子, 由正四丁基铵十钨酸盐和邻苯二酚反应, 得到了钨酶活性结构因子仿生配合物(NH3CH2CHNH2CH3)2[WVIO2(OC6H4O)2], 用单晶X射线衍射测定了其晶体结构, 晶体属单斜晶系, 空间群为P21/n, a＝1.1099(3) nm, b＝1.0416(3) nm, c＝1.8874(6) nm, β＝96.492(6)°, V＝2.1679(11) nm3, z＝4, R1＝0.0445, wR2＝0.0682; 并对它进行了IR, 1H NMR和UV-Vis谱学表征. 利用NMR研究了其与三磷酸腺苷(ATP)的相互作用, 结果发现手性特征的1,2-丙二胺及邻苯二酚苯环的1H化学位移在与ATP混合前后均呈现出较大的差异, 分析得出: 配合物中的金属离子在D2O中大多数均以W(V)价态存在, 但在与ATP共存时转化为W(VI), 并与配体发生了解离.     

二苯并18冠6及二苯并24冠8与六聚钼钨杂多酸超分子配合物的合成与晶体结构

报道了两种超分子配合物［Ｎａ（ＤＢ１８Ｃ６）（ＣＨ＿３ＯＨ）］＿２Ｗ＿４Ｍｏ＿２Ｏ＿（１９）·（ＤＢ１８Ｃ６）·（ＣＨ＿３ＯＨ）（Ⅰ）和［Ｎａ（ＤＢ２４Ｃ８）］＿２Ｗ＿１Ｍｏ＿５Ｏ＿（１９）（Ⅱ）的合成方式，用元素分析、电子能谱、ＩＲ和１ＨＮＭＲ等手段进行了表征，并用Ｘ射线测定了晶体结构。结构分析表明：配合物（Ⅰ）属单斜晶系，空间群为Ｐ２１／ｃ，晶胞参数：α＝１．８６９９（５）ｎｍ，ｂ＝１．９５４３（５）ｎｍ，ｃ＝２．２８０８（６）ｎｍ，β＝１１２．８７°，Ｚ＝４．冠醚与多酸根之间通过Ｎａ＋在ＤＢ１８Ｃ６空腔中的镶嵌和Ｏ—Ｎａ—Ｏ键的桥联结合在一起。超分子配合物（Ⅱ）则为Ｎａ＋与ＤＢ２４Ｃ８作用形成配位阳离子，然后与多酸阴离子静电吸引相结合。不同空腔孔径的冠醚与钼钨杂多酸配位时呈现出分子识别与选择性。     

Synthesis and Crystal Structure of a New Oxovanadium（V） Multicomponent Complex with Acylhydrazone and Benzoylhydrazine

A new oxovanadium（V） complex with the mixed ligand of 2-oxopropionic acid benzoylhydrazone （C10H10N2O3） and benzoylhydrazine （C7H8N2O）, VO（C7H7N2O）（C10H9N2O3）, has been synthesized. Its structure was determined by single crystal X-ray diffraction analysis. The crystal belongs to monoclinic system with space group P21/n and cell parameters： a=1.1136（4） nm, b=0.6217（2） nm, c=2.6038（9） nm, β=97.182（6）°, V= 1.7887（11） nm^3, Z=4, F（000）=836, Mr=407.28, Dc= 1.512 g/cm^3,μ （Mo Kα） =0.592 mm^-1, R1 =0.0445, wR2= 0.1203. Vanadium atom is 6-coordinated by carboxyl and carbonyl O atoms and N atom of one tridentate C10H10N2O3 to form two stable five-membered rings with the same edge, and the other coordinated atoms of N and O come from one bidentate benzoylhydrazine C7H8N2O. The title complex has a six-coordinated V center [VO（N2O3）] with a distorted octahedral arrangement. In the crystal lattice, there are hydrogen bonding interactions between two molecules.     

Interactions with ATP, DNA Cleavage and Anti-tumor Activities of Complexes with Anions [Mo（V）O2（O2CeH4）2]^3-, [Mo（Ⅴ）0.5W（Ⅵ）0.5O2（O2C6H4）2]^2.5- and [W（Ⅵ）O2（O2C6H4）2]^2-

(NH3CH2CH2NH2)3[Mo(Ⅴ)O2(O2C6H4)2] (1), (NH3CH2CH2NH2)2.5[Mo(Ⅴ)o.sW(Ⅵ)o.502(O2C6H4)2] (2) and(NH3CH2CH2NH2)2[VC(Ⅵ)O2(O2C6H4)2] (3) were synthesized, structurally characterized by X-ray diffraction analysis, and studied on their interactions with ATP, their DNA cleavage activities and antitumor properties. The redox state of molybdenum was not changed on going from crystal to aqueous solutions in complexes 1 and 2, while tungsten underwent reduction from W(VI) to W(V) in complexes 2 and 3. ATP promoted the oxidation of both molybdenum and tungsten from M(Ⅴ) to M(Ⅵ) and the hydrolysis of catecholate ligands in solution consisting of ATP and the complexes. Complex 1 possesses fairly good activity to DNA cleavage and against tumor S180 in mice, and is more effective than the control drug cyclophosphamide under the identical conditions. However, complexes 2 and 3 exhibited marginal effectiveness. The effectiveness of anti-tumor of the complexes was related positively to their DNA cleavage activities and their hydrolysis of catecholate ligands.     

[Na(DB18C6)(CH3CN)]2Mo6O19的合成、晶体结构及谱学表征

A novel super-molecular complex, [Na(DB18C6)(CH₃CN)]₂Mo₆O₁₉, was obtained by solvothermal reaction and characterized by elementary analysis, IR, ¹H NMR, gumbc spectrum and X-Ray diffraction experiment. The compound crystallizes in monoclinic space group P2₁/n with a=1.187 1(3) nm, b=2.096 3(6) nm, c=1.415 8(4) nm, β=110.854(5)° and Z=4. The complex contains four basic units: Na⁺, CH₃CN, DB₁₈C₆和Mo₆O₁₉^2-. Sodium ions located in the cavity of dibenzo-18-crown-6 with 6 Na-O bonds and the crown ether-sodium ion complex is supported on the terminal oxygen atoms of the typical Lindqvist isopolyanion Mo₆O₁₉^2- via the coordinative interactions. Mo₆O₁₉^2- located between two DB₁₈C₆ and led to the formation of the “hamburger” structure. The crystal is stabilized by van der waals force and interaction of π-π system. CCDC: 272936.     

手性NMR位移试剂在有机磷酰胺酯类杀虫剂对映异构体测定中的应用

本工作利用手性位移试剂Eu(hfc)Eu(tfc)_3和Pr(hfc)_3对通式为剂进行了~1H、~(13)C和~(31)P NMR研究,观察了对映异构体在手性条件下在NMR谱图上的反映。结果表明,在手性位移试剂作用下,用~1H NMR谱仅能测定结构简单例如R为CH_3的化合物的光学纯度,但采用~(31)P{~1H}技术则可方便有效地测定结构复杂的该类化合物的光学纯度。本工作还对硫酮式和硫醇式两类硫代磷酰胺酯与手性位移试剂的络合模型作了初步讨论。